
Evinova provides digital health software to streamline clinical development for sites, sponsors, and CROs. Its Unified Trial Solution enables remote patient monitoring, connected devices, eConsent, eCOA, and telemedicine through a single integrated app. The Drug Development Suite uses data and AI to accelerate study design, portfolio management, and operational excellence, with strong security and global compliance. The platform integrates with EDC, safety, and CTMS systems and supports multiple therapeutic areas across 40+ countries, reducing patient burden and trial timelines.

Evinova provides digital health software to streamline clinical development for sites, sponsors, and CROs. Its Unified Trial Solution enables remote patient monitoring, connected devices, eConsent, eCOA, and telemedicine through a single integrated app. The Drug Development Suite uses data and AI to accelerate study design, portfolio management, and operational excellence, with strong security and global compliance. The platform integrates with EDC, safety, and CTMS systems and supports multiple therapeutic areas across 40+ countries, reducing patient burden and trial timelines.
WHY JOIN US? Evinova is a health-tech business, accelerating the delivery of better health outcomes by propelling the life sciences sector forward in digital health, from the inside. Through our application of science-based expertise, evidence-led rigour, and human insight, our digital solutions are deliberately designed so that everyone can reach better health outcomes together. Evinova is a health-tech business within the AstraZeneca Group.
Digital health, the point at which healthcare, technology, data and analytics converge, is the subject of phenomenal promise, with the World Health Organisation believing it has the potential to improve health for everyone. At AstraZeneca, we’ve been working hard to make this a reality, with the years of experience we have accumulated enabling us to now embed digital health at scale across R&D.
To achieve our goal of improving patient experience and outcomes AstraZeneca has Digital Health as one of the top 4 strategic priorities for the company, details on digital health strategy can be found here. Oncology is the largest therapeutic area within AstraZeneca and second highest cause of death globally, with AstraZeneca’s ambition to eliminate cancer as a cause of death.
Recognizing the importance of individualized flexibility, our ways of working allow employees to balance personal and work commitments while ensuring we continue to create a strong culture of collaboration and teamwork by engaging face-to-face in our offices 3 days a week. Our head office is purposely designed with collaboration in mind, providing space where teams can come together to strategize, brainstorm and connect on key projects.
About The Opportunity As an Associate Director Scientist within Evinova Endpoints, you will serve as a subject matter expert in Clinical Outcome Assessments (COAs) and quantitative evidence generation spanning statistical analyses, endpoint development, and data management for both established and novel endpoints. You will lead advanced COA analytics that articulate the patient benefit of new medicines, directly shaping the development and commercialization of innovative therapies and digital health solutions.
You will set strategic oversight for quantitative evidence generation at both study team and therapeutic area levels, designing analytic approaches to close evidence gaps. Your work will drive quantitative clinical programming for validation and exploratory analyses using biosensor and wearable data and COA data to identify and evaluate symptoms, function, health related quality of life, and other patient centric concepts of clinical benefit across the drug development lifecycle. Therapeutic areas include Oncology, Cardiovascular, Renal and Metabolism, and Respiratory and Immunology, among others.
You will own the clinical data flow and management strategy, collaborating closely with product engineers to ensure robust, scalable pipelines. Responsibilities include overseeing project level work through cross functional collaboration, and developing and executing analysis plans to generate evidence that supports clinical validity of endpoints. Success in this role relies on strong partnerships with internal teams such as Study Teams, Strategy, Data Science, COA Measurement, and Product and external stakeholders such as Global and Clinical Study Teams and partners, consistently upholding patient centricity, diversity, sustainability, and scientific rigor.
Accountabilities
Qualifications Education
Skills And Experience
Desirable For The Role
SO, WHAT’S NEXT? To be considered for this exciting opportunity, please complete the full application on our website at your earliest convenience – it is the only way that our Recruiter and Hiring Manager can know that you feel well qualified for this opportunity. If you know someone who would be a great fit, please share this posting with them.
Where can I find out more?
Are you interested in working at Evinova, apply today! AstraZeneca is an equal opportunity employer that is committed to diversity and inclusion and providing a workplace that is free from discrimination. AstraZeneca is committed to accommodating persons with disabilities. Such accommodation is available on request in respect of all aspects of the recruitment, assessment and selection process and may be requested by emailing AZCHumanResources@astrazeneca.com.
The annual base pay for this position ranges from $149,052 - $195,500 USD. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program. Benefits offered included a qualified retirement program 401(k) plan paid vacation and holidays; paid leaves; and, health benefits including medical, prescription drug, dental, and vision coverage in accordance with the terms and conditions of the applicable plans. Additional details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base pay (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors. Date Posted 14-Jan-2026
Closing Date 29-Jan-2026
Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.